1. Home
  2. EH vs IRWD Comparison

EH vs IRWD Comparison

Compare EH & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EHang Holdings Limited ADS

EH

EHang Holdings Limited ADS

HOLD

Current Price

$9.88

Market Cap

745.8M

Sector

Industrials

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$4.25

Market Cap

663.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EH
IRWD
Founded
2014
1998
Country
China
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
745.8M
663.6M
IPO Year
2019
2009

Fundamental Metrics

Financial Performance
Metric
EH
IRWD
Price
$9.88
$4.25
Analyst Decision
Strong Buy
Buy
Analyst Count
3
3
Target Price
$22.47
$7.67
AVG Volume (30 Days)
505.1K
1.7M
Earning Date
05-26-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1400.00
EPS
N/A
0.15
Revenue
N/A
$298,276,000.00
Revenue This Year
$33.23
$57.95
Revenue Next Year
$73.83
$4.39
P/E Ratio
N/A
$27.03
Revenue Growth
N/A
8.88
52 Week Low
$9.06
$0.55
52 Week High
$20.44
$5.78

Technical Indicators

Market Signals
Indicator
EH
IRWD
Relative Strength Index (RSI) 38.27 59.62
Support Level $9.06 $3.07
Resistance Level $11.94 $4.50
Average True Range (ATR) 0.41 0.23
MACD -0.09 0.02
Stochastic Oscillator 4.41 83.03

Price Performance

Historical Comparison
EH
IRWD

About EH EHang Holdings Limited ADS

EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: